Atlas Trials

Immune Response Evaluation in Oligorecurrent and Oligoprogressive Prostate Cancer Patients Treated With SBRT

Clinical trial NCT04624828 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04624828
Sponsor
Istituto Clinico Humanitas
Status
ACTIVE_NOT_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Oligorecurrent and Oligoprogressive Prostate Cancer Patients
Start date
2020-10-19
Primary completion
2026-07-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.